Indivior News
Here are all todays headlines related to Indivior News. If you wish to drill deeper to view past Indivior News items, follow the next 20 headlines link at the foot of the page.
18-06-2018
Indivior has won a temporary restraining order by a US court compelling rival drugmaker Dr Reddy's Labs to immediately stop any launch activities related to its generic version of Suboxone Film.
15-06-2018
Intercontinental Hotels: JP Morgan upgraded to neutral with a target price of 4,350p.
15-06-2018
Indivior's main revenue-generating product, Suboxone film, came under pressure overnight as rival Dr Reddy's Labs and Mylan won regulatory approval to its generic version of the sublingual film.
31-05-2018
Shares in Indivior were hit after the drug developer was subpoenaed by the California Department of Insurance over its Suboxone treatment for opioid addiction.
25-05-2018
Indivior has applied to Australian regulators for its Sublocade monthly treatment injection for opioid dependence.
15-05-2018
Despite a strong run in its shares, Citi still saw potential upside from the delay of generic versions of Indivior's Suboxone beyond 2018, but still warned of "conservatively modelled generic competition".
15-05-2018
Indivior: Citigroup downgrades to neutral with a target price of 500p.
14-05-2018
Indivior has reached a settlement to resolve patent litigation it had filed over its Suboxone treatment for opioid addiction against Par Pharmaceutical.
08-05-2018
Encouraged by Indivior's update on the launch of its Sublocade monthly opioid addiction treatment, Jefferies showed its confidence in the drug maker with an improved target price and a reiterated 'buy' rating.
08-05-2018
Just Group: Deutsche Bank initiates at hold with a target price of 170p.
02-05-2018
Indivior's revenues fell 6% in the first quarter even though sales volumes improved, as the company's opioid addiction treatment came under pressure from generic competition and trade de-stocking in the USA.
20-04-2018
(WebFG News) - Indivior has filed a new drug submission (NDS) with Health Canada's Therapeutic Drugs Directorate, it announced on Friday, for its 'SUBLOCADE' (buprenorphine extended-release) injection, for subcutaneous use for the treatment of moderate-to-severe opioid use disorder (OUD), as part of a complete treatment plan to include counseling and psychosocial support.
09-04-2018
BHP Billiton: Societe Generale upgrades to buy with a target price of 1,600p.
05-04-2018
Indivior has reacted to losing a recent court case by suing companies who are developing generic versions of its opioid addiction treatment .
29-03-2018
Indivior announced on Thursday that its subsidiary Indivior UK and C4X Discovery Holdings have entered into a license agreement whereby Indivior UK obtained exclusive global rights to develop and commercialize C4X's oral orexin-1 receptor antagonist programme.
23-03-2018
Mitie Group: Barclays upgrades to overweight with a target price of 180p.
23-03-2018
Indivior warned of a potential "rapid and material loss" of sales from its main revenue-generating product after a US court found a rival generic challenger of the drug did not infringe on its patents.
01-03-2018
Indivior has launched its new once-a-month version of its opioid addiction treatment in the US amid a Donald Trump's 'war on opioid addiction'.
15-02-2018
Tullow oil: Barclays downgrades to equal weight with a target price of 190p.
15-02-2018
Jefferies, RBC Capital Markets and Numis reiterated their positive recommendations on Indivior as the opioid addiction drug maker's shares slipped on the back of final results on Thursday.
Stock News headlines are gathered from financial news sources around the web. Views and opinions on each item are from their respective authors and website. They are not opinions of LiveCharts.co.uk
Get a free widget for your website with our latest headlines.
You can now add our live prices and new headlines to your website.The news widget features quotes for Oil prices, spot Gold price and Indices plus a choice of news channel for healines.
Top Shares pages
- Share price quotes
- Share charts
- Share watch list
- Company Results Calendar
- Top Large UK Shares
- UK Market Sectors
- Stock market news
- Company news
- Share tips
- A-Z company search
More share features
POPULAR Share Prices
- Royal Mail share price
- Lloyds share price
- HSBC share price
- Barclays share price
- Prudential share price
- Santander share price
- NEXT share price
- Diageo share price
- BP share price
- Vodafone share price
- British Airways
- Centrica share price
- Tesco share price
- Taylor Wimpey Share Price
- National Grid
- GKP Share Price
- Marks and Spencer
- Rolls Royce
- Rio Tinto
- THG Share Price
- Aviva Share Price
- Boil Share price
- Easyjet Share Price
- Genedrive Share Price
- SSE Share Price
- IAG Share Price
- Boohoo share price
- HE1 share price
- AVCT share price
- BOOM share price